Reed Elsevier PLCRUK:NYQ

69.04
0.17 / 0.25%
97.79k
19.49%
1.16
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Nov 26 2014 21:05 GMT.

Summary

Reed Elsevier PLC (RUK:NYQ) set a new 52-week high during Wednesday's trading session when it reached 69.27. Over this period, the share price is up 19.22%.

52-week range
Today
55.93
Dec 12 2013
69.27
Nov 26 2014
Markit short selling activity
Low
Medium
High
Open68.99
Day high69.27
Day low68.80
Bid--
Offer--
Previous close68.87
Average volume63.21k
Shares outstanding284.08m
Free float283.18m
P/E (TTM)22.67
Market cap19.47bn USD
EPS (TTM)3.05 USD
Annual div (TTM)1.67 USD
Annual div yield (TTM)2.42%
Div ex-dateAug 06 2014
Div pay-dateSep 04 2014
Data delayed at least 15 minutes, as of Nov 26 2014 21:05 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Reed Elsevier PLC+3.34%+9.52%+9.43%+19.49%+117.52%
S&P 500 INDEX+0.98%+5.67%+7.96%+14.70%+89.91%
Data delayed at least 15 minutes, as of Nov 26 2014 21:05 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.